Menu
Recruiting NCT06770972

Family Foundations for Individuals Pregnant Via ART

No phase Interventional Assisted Reproductive Technology

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Family Foundations.
Who it may be relevant to
Registry conditions: Assisted Reproductive Technology. Basic parameters: from 18 years · Female.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Family Foundations for Individuals Pregnant Via Assisted Reproductive Technology

Overview

The purpose of this study is to help expectant mothers build a coparenting bond and improve communication with a support person (co-caregiver). Participation will include completing two online surveys (one at 12-30 weeks gestation \& one at 3 months postpartum), providing two at-home bloodspot collections and returning the collections via mail. Studies suggest that stress increases inflammation. Investigators aim to explore this by collecting a small amount of blood at the first and last session. Participants will also attend 9 virtual one-two hour Family Foundations (FF) intervention sessions (at no cost to participants) with a supportive co-caregiver. Total time commitment will be 18 hours, max, over a 6 month period.

Interventions

  • Behavioral Family Foundations
    The FF intervention is 9 sessions, 5 in the prenatal period and 4 in the postpartum period.

Primary outcome measures

  • Change in Depressive Symptoms [Time frame: From enrollment to the end of intervention at 6 months postpartum]
  • Change in social support [Time frame: From enrollment to the end of intervention at 6 months postpartum]
  • Change in Anxiety Symptoms [Time frame: From enrollment to the end of intervention at 6 months postpartum]
  • Change in symptoms of perceived stress [Time frame: From enrollment to the end of intervention at 6 months postpartum]
  • Change in communication [Time frame: From enrollment to the end of intervention at 6 months postpartum]
  • Change in symptoms of post-traumatic stress [Time frame: From enrollment to the end of intervention at 6 months postpartum]
Secondary outcome measures (1)
  • Change in levels of high sensitivity C-reactive protein (mg/dL) [Time frame: From enrollment to the end of treatment at 6 months postpartum]

Eligibility criteria

Inclusion criteria

  • Pregnant individuals via ART, at least 18 years of age
  • Have a caregiving partner (e.g. spouse, grandparent; nanny; friend) who will attend sessions
  • Provision of signed and dated informed consent form
  • Stated willingness to comply with all study procedures and availability for the duration of the study
  • English speaking

7\. Access to and familiarity with a tablet, smartphone, or computer

Exclusion criteria

  • Psychosis
  • Perinatal loss (current) - history of loss is OK
  • Individuals outside of the US
  • Do not have smartphones, tablets, computers (the FF class is virtual)

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Single blind
Primary purpose
Other

Study locations

United States · 1 center
  • Cedars Sinai Medical Center — Los Angeles

Identifiers

NCT: NCT06770972 · STUDY00003470

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗